A better buy-in window may exist right now for The Clorox Company (CLX)

The Clorox Company (NYSE: CLX) stock fell -4.71% on Friday to $137.76 against a previous-day closing price of $144.57. With 3.33 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.38 million shares. During the session, the Household & Personal Products company that operates in wider Consumer Defensive sector, reached to the highest price of $143.53 whereas the lowest price it dropped to was $135.81. The 52-week range on CLX shows that it touched its highest point at $186.86 and its lowest point at $120.50 during that stretch. It currently has a 1-year price target of $135.27. With its current market cap of 17.01 billion, CLX has annualized dividend of $4.72 while the current yield stands at 3.43%. Beta for the stock currently stands at 0.18.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLX was down-trending over the past week, with a drop of -4.78%, but this was down by -6.07% over a month. Three-month performance dropped to -7.93% while six-month performance fell -17.50%. The stock lost -16.82% in the past year, while it has lost -20.99% so far this year. A look at the trailing 12-month EPS for CLX yields 3.69 with Next year EPS estimates of 5.26. For the next quarter, that number is 0.93. This implies an EPS growth rate of -24.20% for this year and 27.94% for next year. EPS is expected to decline by -6.40% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 2.50%.

Float and Shares Shorts:

At present, 123.18 million CLX shares are outstanding with a float of 122.05 million shares on hand for trading. On Jul 14, 2022, short shares totaled 7.45 million, which was 6.06% higher than short shares on Jun 14, 2022. In addition to Ms. Linda Rendle as the firm’s CEO & Director, Mr. Kevin B. Jacobsen serves as its Exec. VP & CFO.

Institutional Ownership:

Through their ownership of 80.50% of CLX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 51.08% of CLX, in contrast to 40.38% held by mutual funds. Shares owned by individuals account for 40.21%. As the largest shareholder in CLX with 11.52% of the stake, The Vanguard Group, Inc. holds 14,180,335 shares worth 14,180,335. A second-largest stockholder of CLX, SSgA Funds Management, Inc., holds 8,128,814 shares, controlling over 6.60% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in CLX, holding 7,640,959 shares or 6.21% stake. With a 2.95% stake in CLX, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 3,627,771 shares are owned by the mutual fund manager. The Vanguard Mid Cap Index Fund, which owns about 2.30% of CLX stock, is the second-largest Mutual Fund holder. It holds 2,833,413 shares valued at 399.45 million. Vanguard 500 Index Fund holds 2.21% of the stake in CLX, owning 2,724,001 shares worth 384.03 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLX since 18 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 7 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 2 give it an OVERWEIGHT rating, and 2 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CLX analysts setting a high price target of $165.00 and a low target of $114.00, the average target price over the next 12 months is $134.73. Based on these targets, CLX could surge 19.77% to reach the target high and fall by -17.25% to reach the target low. Reaching the average price target will result in a decline of -2.2% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. CLX will report FY 2023 earnings on 08/03/2023. Analysts have provided yearly estimates in a range of $5.80 being high and $4.70 being low. For CLX, this leads to a yearly average estimate of $5.27. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. The Clorox Company reported $0.93 EPS against a consensus estimate of $0.93. The surprise factor in the prior quarter was $0.39. Based on analyst estimates, the high estimate for the next quarter is $1.50 and the low estimate is $1.21. The average estimate for the next quarter is thus $1.36.

Summary of Insider Activity:

Insiders traded CLX stock several times over the past three months with 2 Buys and 5 Sells. In these transactions, 1,751 shares were bought while 3,664 shares were sold. The number of buy transactions has increased to 41 while that of sell transactions has risen to 51 over the past year. The total number of shares bought during that period was 65,505 while 12,190 shares were sold.

Leave a Comment

Your email address will not be published.